header-1

    Share your expertise and register for a $25 Pharma card.

    Have you ever had a second surgical look at a patient who you know had an adhesion barrier placed in a previous surgery?

    In what percentage of your repeat elective C-sections do you typically use an adhesion barrier?

    Please rate your level of agreement with the following statement:

    Not ready to sign up yet?
    Learn more about SEPRAFILM® for C-sections.

    Indication

    Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

    Important Safety Information

    Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

    Please see full perscribing information.

    References: 1. Lyell DJ, Caughey AB, Hu E, Daniels K. Peritoneal closure at primary cesarean delivery and adhesions. Obstet Gynecol. 2005;106:275-280. 2. Morales KJ, Gordon MC, Bates GW Jr. Postcesarean delivery adhesions associated with delayed delivery of infant. Am J Obstet Gynecol. 2007;196(online):461.e1-461.e6. 3. Fushiki H, Ikoma T, Kobayashi H, Yoshimoto H. Efficacy of Seprafilm as an adhesion prevention barrier in cesarean sections. Obstet Gynecol Treatment. 2005;91:557-561. 4. Hamel K. Incidence of adhesions at repeat cesarean delivery. Am J Obstet Gynecol. 2007;196(online):e31-e32.

    header-1

      Share your expertise and register for a $25 Pharma card.

      Thinking about all of the surgical procedures you perform, what percentage are repeat elective C-sections?

      Please rate your level of agreement with the following statements:

      Not ready to sign up yet?
      Learn more about SEPRAFILM® for C-sections.

      Indication

      Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

      Important Safety Information

      Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

      Please see full perscribing information.

      References: 1. Morales KJ, Gordon MC, Bates GW Jr. Postcesarean delivery adhesions associated with delayed delivery of infant. Am J Obstet Gynecol. 2007; 196(online):461.e1-461.e6. 2. Makoha FW, Felimban HM, Fathuddien MA, Roomi F, Ghabra T. Multiple cesarean section morbidity. Int J Gynecol Obstet. 2004;87:227-232.

      header-1

        Get your Pharma card.

        In order to receive your complimentary $25 Pharma card, please verify or fill in your contact information below.

        What can I get with my Pharma card?

        Choose medically relevant gift items from a great selection.

        Gifts include:

        • Books
        • Medical posters
        • Charts
        • Pocket guides

        * Indicates required information.

        Not ready to sign up yet?
        Learn more about SEPRAFILM® for C-sections.

        Indication

        Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

        Important Safety Information

        Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

        Please see full perscribing information.

        Reference: 1. Fushiki H, Ikoma T, Kobayashi H, Yoshimoto H.Efficacy of Seprafilm as an adhesion barrier in cesarean sections. Obstet Gynecol Treatment. 2005;91:557-561.